Table 3 Medications taken for chronic migraine prior to occipital nerve stimulation
From: Long-term outcomes of occipital nerve stimulation for chronic migraine: a cohort of 53 patients
|  | Number of patients who tried drug (% of cohort n = 53) | Daily dose range (mg) | Mean maximum daily dose (mg) |
|---|---|---|---|
Beta-Blockers | 42 (79.2 %) | 30–320 | 140.80 |
Topiramate | 49 (92.4 %) | 25–400 | 170.65 |
Sodium Valproate | 47 (88.6 %) | 300–2500 | 1047.50 |
Gabapentin | 51 (96.2 %) | 300–3600 | 2206.97 |
Pregabalin | 32 (60.3 %) | 50–600 | 384.16 |
Flunarizine | 36 (67.9 %) | 5–20 | 8.79 |
Pizotifen | 45 (84.9 %) | 1.5–4.5 | 2.39 |
Methysergide | 44 (83.0 %) | 1–12 | 6.10 |
Tricyclic Antidepressant: | 51 (96.2 %) | – | – |
 Amitriptyline | 44 (83.0 %) | 10–150 | 56.31 |
 Dosulepin | 28 (52.8 %) | 25–225 | 101.73 |
NSAID | 42 (79.2 %) | – | – |
Acupuncture | 3 (5.7 %) | – | – |
Botox | 7 (13.2 %) | – | – |
IV DHE | 45 (84.9 %) | – | – |
GONB | 53 (100 %) | – | – |